帕洛西丁诱导的黑色毛发的舌头和死性形形质:一个病例报告
Zhuang Ying Lee1, Manjit Dhillon2
1Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN, UK. leezy391@gmail.com.
Journal of medical case reports
|November 29, 2025
概括
黑色毛发的舌头和死性形形质是良性口腔疾病,可以与帕洛克塞丁使用有关. 停止服用药物并保持口腔卫生导致一名患有这两种疾病的患者显著改善.
科学领域:
- 口腔医学是指口腔医学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 黑色毛发的舌头 (lingua villosa nigra) 是延长的 filiform 乳头的良性状况.
- 垂死性形形质是一种小唾液腺的良性炎症性疾病.
- 这两种情况都有共同的危险因素,如吸烟,酒精和某些药物,包括帕洛.
研究的目的:
- 突出帕洛克塞丁与黑色毛发舌头和死性形形质的发展之间的潜在关联.
- 强调在患有相关风险因素和口腔病变的患者中考虑这些疾病的重要性.
主要方法:
- 一个案例介绍,一名27岁的女性在开始服用帕洛克后经历了反复出现的口腔,随后出现了黑色毛发的舌头.
- 口腔病变的保守管理.
- 停止帕洛克塞丁治疗并开始替代性抗抑郁药.
主要成果:
- 患者出现了口腔和黑色毛发的舌头.
- 口腔病变在 Paroxetine 停用后显著改善.
- 精神健康没有通过帕洛克塞丁改善.
结论:
- 在口腔病变的差分诊断中,应考虑黑色毛发的舌头和死性形形质,特别是在具有危险因素的患者中.
- 保守的管理,包括消除致病因素和良好的口腔卫生,是有效的.
- 准确的诊断至关重要,因为死性甲可模仿更严重的病理.
- 这些情况可能代表帕罗克塞丁的罕见副作用,在药物咨询期间需要讨论.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
609
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
609
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
857
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
857
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
576
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
576


